发明授权
US07652022B2 Diaryl urea derivatives useful for the treatment of protein kinase dependent diseases
失效
用于治疗蛋白激酶依赖性疾病的二芳基脲衍生物
- 专利标题: Diaryl urea derivatives useful for the treatment of protein kinase dependent diseases
- 专利标题(中): 用于治疗蛋白激酶依赖性疾病的二芳基脲衍生物
-
申请号: US10515113申请日: 2003-05-28
-
公开(公告)号: US07652022B2公开(公告)日: 2010-01-26
- 发明人: Andreas Floersheimer , Pascal Furet , Paul William Manley , Guido Bold , Eugen Boss , Vito Guagnano , Andrea Vaupel
- 申请人: Andreas Floersheimer , Pascal Furet , Paul William Manley , Guido Bold , Eugen Boss , Vito Guagnano , Andrea Vaupel
- 申请人地址: CH Basel
- 专利权人: Novartis AG
- 当前专利权人: Novartis AG
- 当前专利权人地址: CH Basel
- 优先权: GB0212413.9 20020529; GB0305684.3 20030312; GB0309219.4 20030423
- 国际申请: PCT/EP03/05634 WO 20030528
- 国际公布: WO03/099771 WO 20031204
- 主分类号: A01N43/54
- IPC分类号: A01N43/54 ; A01N43/40 ; A61K31/505 ; A61K31/44 ; C07D239/02
摘要:
The invention relates to the use of diaryl urea derivatives in the treatment of protein kinase dependent diseases or for the manufacture of pharmaceutical compositions for use in the treatment of said diseases, methods of use of diaryl urea derivatives in the treatment of said diseases, pharmaceutical preparations comprising diaryl urea derivatives for the treatment of said diseases, diaryl urea derivatives for use in the treatment of said diseases, novel diaryl urea derivatives, pharmaceutical preparations comprising these novel diaryl urea derivatives, processes for the manufacture of the novel diaryl urea derivatives, the use or methods of use of the novel diaryl urea derivatives as mentioned above, and/or these novel diaryl urea derivatives for use in the treatment of the animal or human body.
公开/授权文献
信息查询
IPC分类: